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Abstract Multiple sclerosis (MS) commonly affects
occupational function. We investigated the link between
brain MRI and employment status. Patients with MS
(n = 100) completed a Work Productivity and Activity
Impairment (WPAI) (general health version) survey mea-
suring employment status, absenteeism, presenteeism, and
overall work and daily activity impairment. Patients
‘‘working for pay’’ were considered employed; ‘‘tem-
porarily not working but looking for work,’’ ‘‘not working
or looking for work due to age,’’ and ‘‘not working or
looking for work due to disability’’ were considered not
employed. Brain MRI T1 hypointense (T1LV) and T2
hyperintense (T2LV) lesion volumes were quantified. To
assess lesional destructive capability, we calculated each
subject’s ratio of T1LV to T2LV (T1/T2). Normalized
brain parenchymal volume (BPV) assessed brain atrophy.
The mean (SD) age was 45.5 (9.7) years; disease duration
was 12.1 (8.1) years; 75 % were women, 76 % were
relapsing-remitting, and 76 % were employed. T1LV, T1/
T2, Expanded Disability Status Scale (EDSS) scores, and
activity impairment were lower and BPV was higher in the
employed vs. not employed group (Wilcoxon tests,
p\ 0.05). Age, disease duration, MS clinical subtype, and
T2LV did not differ between groups (p[ 0.05). In multi-
variable logistic regression modeling, adjusting for age,
sex, and disease duration, higher T1LV predicted a lower
chance of employment (p\ 0.05). Pearson correlations
showed that EDSS was associated with activity impairment
(p\ 0.05). Disease duration, age, and MRI measures were
not correlated with activity impairment or other WPAI
outcomes (p[ 0.05). We report a link between brain
atrophy and lesions, particularly lesions with destructive
potential, to MS employment status.
Keywords Employment  Productivity  Multiple
sclerosis  MRI  Brain atrophy  Brain lesions  Disability
Introduction
The compromised ability to perform occupational function
and unemployment is commonly seen in multiple sclerosis
(MS) [1–8]. Impaired work performance is related to a
variety of disease manifestations including physical dis-
ability, cognitive impairment, psychological factors, pain,
and fatigue [1–4, 6–13]. Furthermore, in addition to the
financial impact of occupational limitations, such impair-
ment may significantly lower quality of life [2, 14].
MRI of the brain is a valuable tool for the diagnosis and
longitudinal monitoring of patients with MS [15]. MRI
imaging can depict a variety of effects of the disease pro-
cess, such as the development of T1 hypointense lesions,
T2 hyperintense lesions, and atrophy [15, 16]. A growing
body of evidence has linked MRI-defined disease severity
to key clinical manifestations such as physical disability,
mood disturbances, and cognitive impairment [15–24].
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However, to date, the relationship between MRI and
occupational function has not been evaluated.
In a recent cross-sectional study, we administered a
work productivity scale to patients with MS and identified
a role for disability, depression, fatigue, and anxiety in
impairment of occupational functions [2]. In the present
study, we extended our previous observations in this cohort
by examining the available MRI scans to assess the link
between brain lesions/atrophy and employment status/
productivity.
Methods
Subjects and clinical evaluation
As part of the Comprehensive Longitudinal Investigation
of Multiple Sclerosis at Brigham and Women’s Hospital
(CLIMB) study [25], we previously reported employment-
related data on 377 patients with a clinically isolated
demyelinating syndrome (CIS) or relapsing-remitting MS
(RRMS), based on the administration of the Work Pro-
ductivity and Activity Impairment (WPAI) questionnaire
(general health version) [2].
The WPAI survey, administered during a scheduled
clinical visit in the CLIMB study, measured employment
status, absenteeism, presenteeism (impairment during
work), overall work impairment, and daily activity
impairment. Patients who reported ‘‘working for pay’’ were
classified as employed (n = 76). While those ‘‘temporarily
not working but looking for work,’’ ‘‘not working or
looking for work due to age,’’ and ‘‘not working or looking
for work due to disability’’ were considered not employed
(n = 16). Patients who were not classified as employed or
not employed (n = 8) because they were working in home
(n = 4), volunteering (n = 1), or in school (n = 3) were
excluded from the analysis comparing the employed vs. not
employed groups.
During the same clinical visit, patients also underwent a
neurologic examination by an MS neurologist to rate
physical disability using the Expanded Disability Status
Scale (EDSS) [26]. To qualify for this MRI-based sub-
study, patients were required to have undergone brain
imaging on the assigned CLIMB study MRI scanner using
a consistent acquisition protocol that included a 3D high-
resolution scan and was performed within 90 days of the
clinical visit. One hundred patients were identified, the
clinical and demographic characteristics of whom are
shown in Table 1.
All subjects gave informed consent. This study was
approved by the Partners Health Care ethics committee and
was performed in accordance with the ethical standards of
the 1964 Declaration of Helsinki and its later amendments.
MRI acquisition
Brain MRI was performed in all subjects on a 1.5T scanner
(GE Signa, Milwaukee, WI). Scan acquisitions covered the
whole brain and included an axial T1-weighted spin-echo
(TR/TE: 725/20 ms) and dual-echo T2-weighted (TR/TE2/
TE1: 3000/80/30 ms) series (voxel size 0.94 9 0.94
9 3 mm) and a sagittal 3D MP-RAGE sequence (TR/TE:
8.6/3.8 ms) with a voxel size of 0.94 9 0.94 9 1.2 mm.
T1-weighted spin-echo imaging was repeated 5 min after
0.1 mol/kg intravenous gadolinium (Gd).
MRI analysis: lesions
Brain T1 hypointense (T1LV) and T2 hyperintense lesion
volume (T2LV) were expert-quantified with an edge-find-
ing tool using Jim software (v.5, Xinapse Systems Ltd,
West Bergholt, UK, http://www.xinapse.com/). T2 hyper-
intense lesions were defined as those showing hyperinten-
sity on both the proton density and late echo T2-weighted
images. T1 hypointense lesions (‘‘black holes’’) were
required to show at least partial hyperintensity on the dual-
echo images, but no gadolinium-enhancement (to reduce
the likelihood of including transient lesions) [15]. To assess
a patient’s lesional destructive capability, we calculated the
ratio of T1LV to T2LV (T1/T2) for each subject, based
on our previous work showing the value of this metric
[27–29].
MRI analysis: atrophy
To assess whole brain atrophy, we measured normalized
brain parenchymal volume (BPV) from the 3D MP-RAGE
images using the fully automated segmentation-based
algorithm, Structural Image Evaluation using Normaliza-
tion of Atrophy (SIENAX) [30]. Our method has been
previously detailed [31]. Briefly, the automated process
involved extraction of the brain and CSF volume from the
whole-head input data, followed by affine-registration to a
standardized space. The volumetric scaling factor was then
obtained for normalization by head size. Tissue-type seg-
mentation with partial volume estimation was then con-
ducted to calculate the total volume of brain tissue vs. CSF.
Optimization experiments led to our use of the default
brain extraction threshold of 0.5 to maintain adequate
segmentation in each image set.
Statistical analysis
Baseline descriptive statistics were summarized, and
baseline age, disease duration, EDSS, brain volume mea-
sures, and activity impairment were compared between
employed vs. not employed patients using the Wilcoxon
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rank-sum test. Correlations between patient characteristics
and WPAI General Health scores were assessed using
Pearson’s correlation coefficient for all variables except for
EDSS, for which the associations were measured using
Spearman’s rho. Logistic regression models were used to
explore whether employment status was associated with
brain volume and lesion volume. Age, sex, and disease
duration were included as covariates in the logistic
regression models. All data analyses were performed using
SAS release 9.3 (SAS Institute, Inc., Cary, NC).
Results
Patient demographic, clinical, and MRI characteristics are
shown in Table 1. Among the 100 patients analyzed in the
correlation analysis, 74 % had absenteeism and 72 % had
presenteeism data. A total of 12 patients had an absen-
teeism score[0, while 33 patients had a presenteeism
score[0. The main results are shown in Tables 2 and 3
and Figs. 1, 2, 3, 4. Seven patients had Gd-enhanced
lesions; however, due to power considerations and study
design, we did not formally compare patients for the
presence or absence of Gd-enhancing lesions in relation to
employment in this study. As shown in Table 2 and
Figs. 1, 2, and 4, T1LV, T1/T2, Expanded Disability Status
Scale (EDSS) scores, and activity impairment were lower
and BPV was higher in the employed vs. not employed
group (Wilcoxon tests, p\ 0.05; Wilcoxon rank-sum tests,
p\ 0.05). Age, disease duration, T2LV, and clinical sub-
type of MS were not significantly different between groups
(p[ 0.05) (Tables 2 and 3, Fig. 3). Spearman’s correlation
coefficient showed that EDSS was associated with activity
impairment (p\ 0.05) (Table 4). However, disease dura-
tion, age, and MRI variables were not correlated with
activity impairment, absenteeism, presenteeism, or overall
work impairment (all p[ 0.05).
Regression Modeling
To further explore the strength of the relationship between
MRI and MS employment status, we developed three
logistic regression models (each adjusting for age, sex, and
disease duration): (1) T1LV vs. employment status, (2) T1/
T2 vs. employment status, and (3) BPV vs. employment
status. In the first multivariable logistic regression model,
we found a statistically significant reduction (p = 0.047) in
the odds of being employed vs. unemployed by 22.4 % for
each 1 mL increase in T1LV. We did not observe a sig-
nificant association between T1/T2 (p = 0.144) or BPV
(p = 0.191) and employment status in the second and third
multivariable models.
Discussion
The major finding in this study is the increased disease
severity as shown by MRI-defined cerebral lesions and
atrophy in MS patients who are not employed vs. those
Table 1 Multiple sclerosis patient characteristics
Age, years: Mean ± SD (range) 45.5 ± 9.7
(19.9–64.8)
Female, n (%) 75 (75.0)
Race, n (%)
Black or African American 4 (4.0)
South Asian 1 (1.0)
White 94 (94.0)
Unknown 1 (1.0)
Employment status, n (%)
Working for pay 76 (76.0)
Working in home 4 (4.0)
Volunteering 1 (1.0)
In school 3 (3.0)
Temporarily not working but looking for
work
3 (3.0)
Not working or looking for work because of
age
2 (2.0)
Not working or looking for work because of
disability
11 (11.0)




MS category, n (%)
Clinically isolated syndrome 6 (6.0)
Relapsing-remitting 76 (76.0)
Secondary progressive 12 (12.0)
Primary progressive 6 (6.0)




T1 hypointense lesion volume, mL:
Mean ± SD (range)
1.3 ± 2.1 (0.0–9.5)
T2 hyperintense lesion volume, mL:
Mean ± SD (range)
4.9 ± 6.7 (0.1–28.3)
T1/T2 lesion volume ratio: Mean ± SD
(range)
0.3 ± 0.2 (0.0–0.7)
EDSS: Mean ± SD (range) 2.2 ± 1.9 (0.0–7.5)
WPAI:GH, mean ± SD, %
Activity impairment (n = 99) 21.0 ± 26.5
Overall work impairment (n = 74) 18.3 ± 25.6
Absenteeism (i.e., percent work time
missed, n = 74)
6.7 ± 19.7
Presenteeism (i.e., days at work but limited
in performing job tasks due to health,
n = 72)
13.5 ± 20.1
n = 100 unless otherwise indicated
EDSS expanded disability status scale, WPAI:GH work productivity
and activity impairment-general health
J Neurol (2015) 262:2425–2432 2427
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Table 2 Clinical/MRI multiple
sclerosis disease variables in
employed vs. not employed
patients
Mean difference
employed (n = 76)






Disease duration -0.008 0.857





T1/T2 LV ratio -0.093 0.012
Activity Impairment -27.125 0.002
EDSS Expanded Disability Status Scale score, BPV brain parenchymal volume, LV lesion volume
a This analysis was conducted among patients who reported any of the following: ‘‘working for pay,’’
‘‘temporarily not working but looking for work,’’ not working or looking for work due to age,’’ and ‘‘not
working or looking for work due to disability.’’ Patients who reported ‘‘working for pay’’ were considered
employed. BPV, T1, and T2 lesion volumes are measured in mL
b p values were estimated using a non-parametric Wilcoxon rank-sum test for two independent samples
c When stratified by employment status, the mean age among employed patients was 44.9 (SD 8.6) with a
range of 27.1–62.6 years and the mean age among not employed patients was 49.3 (SD 10.5) with a range
of 29.8–64.8 years. Note that the regression modeling testing the relationships between MRI and
employment status were adjusted for age, sex, and disease duration (see ‘‘Results’’ Section)
Table 3 Clinical subtype of
multiple sclerosis by
employment status
Employed, n (%) Not employed, n (%)
Clinically isolated syndrome 5 (6.6) 1 (6.3)
Relapsing-remitting 60 (78.9) 10 (62.5)
Secondary progressive 6 (7.9) 4 (25.0)
Primary progressive 5 (6.6) 1 (6.3)
There was no significant difference between employed (n = 76) and not employed (n = 16) groups in
terms of the distribution of multiple sclerosis clinical subtype (p[ 0.05)
Fig. 1 Brain atrophy is associated with MS employment status.
Boxplot with mean (diamond), median, quartiles, 95 % interval
whiskers and outliers. Wilcoxon rank-sum test: p value = 0.036
Fig. 2 Brain T1 hypointense lesion volume is associated with MS
employment status. Boxplot with mean (diamond), median, quartiles,
95 % interval whiskers and outliers. Wilcoxon rank-sum test:
p value = 0.014
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who are employed. Among lesion measures, the destructive
potential as assessed by the overall T1 hypointense burden
and the proportion of T2 hyperintense lesions showing T1
hypointensity were most strongly related to the employ-
ment status. In addition, normalized whole brain volume
was higher in employed vs. not employed patients, sug-
gesting that brain atrophy was also a factor linked to not
employed status.
These findings are perhaps not surprising given that a
range of neurological and neuropsychological dysfunction
in MS, such as physical disability, cognitive impairment,
and mood disturbances, have been linked to both impaired
work performance [1–4, 6–13] and brain structural damage
as defined on MRI scans by lesions and atrophy [22, 32].
Among MRI lesion measures, T1 hypointense lesions have
Fig. 3 Brain T2 hyperintense lesion volume is not associated with
MS employment status. Boxplot with mean (diamond), median,
quartiles, 95 % interval whiskers and outliers. Wilcoxon rank-sum
test: p value = 0.107
Fig. 4 Brain T1/T2 lesion volume ratio is associated with MS
employment status. Boxplot with mean (diamond), median, quartiles,
95 % interval whiskers and outliers. Wilcoxon rank-sum test:
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shown both more specificity for destructive irreversible
damage [33] and better correlations with mental and
physical impairment [24, 34] than T2 hyperintense lesions.
These previous studies are in line with our results that T1
hypointense lesions are also more important for employ-
ment status than T2 hyperintense lesions.
The second major finding was that none of the MRI
variables were associated with activity impairment in the
whole cohort or any work productivity measures in the
employed patients, including overall work impairment,
absenteeism, or presenteeism. These aspects of impairment
were not common in our sample. Thus, the study may have
been underpowered to detect such associations due to the
restricted range of activity impairment. Secondly, the latter
three measures of impairment are only relevant to
employed patients and thus may not have provided suffi-
cient sensitivity. Furthermore, these self-reported measures
may not have been reliable. We did not assess any objec-
tive measures of productivity while working. Finally, the
presence of cognitive reserve [35], which was not assessed
in our study, may have provided adaptive ability for
patients to maintain function, despite the accumulation of
disease-related structural brain changes.
A third finding was the strong relationship between
physical disability, assessed by EDSS score, and both
employment status and activity impairment. Such a rela-
tionship has been long known in MS. However, it was
striking in our data that EDSS score showed a closer link
than the MRI variables to employment and activity
impairment. This important role for disability was seen
from two perspectives. First, the differences between
employed and not employed groups were robust for EDSS
(p\ 0.001), while less robust for MRI brain atrophy and
T1 hypointense lesion variables (p\ 0.05). Second, EDSS
score, but not MRI variables, showed a significant corre-
lation with activity impairment. One possible explanation
for this divergence is the heavy contribution of spinal cord
involvement to the EDSS score [26], whereas only brain
MRI measures were applied in this study. It is likely that
spinal cord involvement, a major contributor to limb and
ambulatory disability [29, 36–41], is a key contributor to
vocational skills, and is poorly reflected in the level of
MRI-defined brain lesions or atrophy in patients with MS
[36].
Our cohort was dominated by mildly affected patients
with relapsing forms of MS. Given that only 18 % of our
patients had progressive forms of MS, further studies are
required to assess the link between brain MRI findings and
employment in advanced forms of the disease. Sample size
should also be taken into account as the not employed
group comprised 16 patients. We are now planning to study
larger cohorts. Additional work is necessary to establish
whether the relationships between MRI and employment
are independent from the effects of cognitive impairment
and fatigue. Because of sample size and the restricted range
of employment impairment, there may have been limited
power to detect the full extent of MRI relationships. It
would be of interest for future studies to test whether other
aspects of MRI-defined involvement in MS, such as spinal
cord [36–41], cortical [42, 43], and diffuse cerebral damage
[44–46], are related to productivity and whether MRI
findings predict longitudinal change of employment status.
Destructive effects of lesions may be particularly promi-
nent using ultra-high-field strength MRI [47]. In summary,
our study demonstrates a clear relationship between brain
MRI and employment status in MS.
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